Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors Article

Villalona-Calero, Miguel A, Diaz, John P, Duan, Wenrui et al. (2022). Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors . 10(1), 10.1186/s40364-022-00386-0

Open Access

cited authors

  • Villalona-Calero, Miguel A; Diaz, John P; Duan, Wenrui; Diaz, Zuanel; Schroeder, Eric D; Aparo, Santiago; Gatcliffe, Troy; Albrecht, Federico; Venkatappa, Siddhartha; Guardiola, Victor; Garrido, Sara; Rubens, Muni; DeZarraga, Fernando; Vuong, Hao

sustainable development goals

authors

publication date

  • June 3, 2022

webpage

keywords

  • BRCA1
  • Biomarkers
  • CANCER
  • DEFECT
  • DNA repair
  • FancD2
  • Fanconi
  • Homologous recombination
  • Immune checkpoint inhibitor
  • Life Sciences & Biomedicine
  • MUTATION
  • Medicine, Research & Experimental
  • Oncology
  • PD-1 BLOCKADE
  • Research & Experimental Medicine
  • Science & Technology
  • THERAPY

Digital Object Identifier (DOI)

publisher

  • BMC

volume

  • 10

issue

  • 1